Publications

Found 6 results
Author Title Type [ Year(Desc)]
Filters: First Letter Of Last Name is D and Author is Dejmek, Milan  [Clear All Filters]
2022
Bouřa, E.; Dejmek, M.; Chalupská, D.; Klíma, M.; Matoušová, M.; Mertlíková-Kaiserová, H.; Misehe, M.; Nencka, R.; Šála, M. Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold. Bioorganic and Medicinal Chemistry Letters 2022, 76 (November), nestránkováno.
2023
Misehe, M.; Matoušová, M.; Dvořáková, A.; Hercík, K.; Škach, K.; Chalupská, D.; Dejmek, M.; Šála, M.; Hájek, M.; Bouřa, E.; et al. Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2/3 kinases. European Journal of Medicinal Chemistry 2023, 260 (November).
Štefek, M.; Chalupská, D.; Chalupský, K.; Zgarbová, M.; Dvořáková, A.; Krafčíková, P.; Li, A. Shi Ming; Šála, M.; Dejmek, M.; Otava, T.; et al. Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors. ACS Omega 2023, 8 (30), 27410-27418.
Dejmek, M.; Brázdová, A.; Otava, T.; Polidarová, M. Pimková; Klíma, M.; Smola, M.; Vavřina, Z.; Buděšínský, M.; Dračínský, M.; Liboska, R.; et al. Vinylphosphonate-based cyclic dinucleotides enhance STING-mediated cancer immunotherapy. European Journal of Medicinal Chemistry 2023, 259 (November).
2024
Kocek, H.; Chalupská, D.; Dejmek, M.; Dvořáková, A.; Zgarbová, M.; Šála, M.; Chalupský, K.; Krafčíková, P.; Otava, T.; Drexler, M.; et al. Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides. RSC Medicinal Chemistry 2024, nestránkováno.
Tóth, L. Julianna; Krejčová, K.; Dejmek, M.; Žilecká, E.; Klepetářová, B.; Slavětínská, L. Poštová; Bouřa, E.; Nencka, R. Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics. Beilstein Journal of Organic Chemistry 2024, 20 (MAY 6 2024), 1029-1036.
xs sm md lg